Ads
related to: history of hepatitis b treatment- Hepatitis B Screening
Discover The Importance Of
Screening To Identify Hepatitis B
- Chronic Hep B Information
Understand Chronic Hep B & Find
Info On Screening For The Disease
- Product Dosage Info
Find Dosage Information For A
Chronic Hep B Treatment Option
- CHB Patient Site
Visit The Official Website Designed
For Chronic Hep B Patients
- Mechanism Of Action
Learn More About The MOA Of A
Chronic Hep B Treatment Option
- Patient Co-Pay Assistance
Discover A Program That May Help
Your Patients Pay For CHB Treatment
- Hepatitis B Screening
Search results
Results From The WOW.Com Content Network
World Hepatitis Day, observed 28 July, aims to raise global awareness of hepatitis B and hepatitis C and encourage prevention, diagnosis, and treatment. It has been led by the World Hepatitis Alliance since 2007 and in May 2010, it received global endorsement from the World Health Organization .
HBsAg (hepatitis B surface antigen) was the first hepatitis B virus protein to be discovered. [15] It consists of small (S), medium (M) and large (L) protein. [16] HBcAg (hepatitis B core antigen) is the main structural protein of HBV icosahedral nucleocapsid and it has function in replication of the virus. [17]
Serious side effects from the hepatitis B vaccine are very uncommon. [13] Pain may occur at the site of injection. [13] It is safe for use during pregnancy or while breastfeeding. [13] It has not been linked to Guillain–Barré syndrome. [13] Hepatitis B vaccines are produced with recombinant DNA techniques and contain immunologic adjuvant. [13]
Hepatitis D is a defective virus that requires hepatitis B to replicate and is only found with hepatitis B co-infection. [17] In adults, hepatitis B infection is most commonly self-limiting, with less than 5% progressing to chronic state, and 20 to 30% of those chronically infected developing cirrhosis or liver cancer. [31]
Hepatitis B immunoglobulin (HBIG) is a human immunoglobulin that is used to prevent the development of hepatitis B [2] and is used for the treatment of acute exposure to HBsAg. [ 3 ] [ 4 ] [ 5 ] Medical uses
The Baruch S. Blumberg Institute was established in 2003 by the Hepatitis B Foundation to conduct focused biomedical research on hepatitis B. Originally known as the Institute of Hepatitis and Virus Research, it was renamed in 2013 to honor its late co-founder and discoverer of the hepatitis B virus, Baruch S. Blumberg.
If the person exposed is an HBsAg positive source (a known responder to HBV vaccine) then if exposed to hepatitis B a booster dose should be given. If they are in the process of being vaccinated or are a non-responder they need to have hepatitis B immune globulin (HBIG) and the vaccine. For known non-responders HBIG and the vaccine should be ...
Lamivudine has been used for treatment of chronic hepatitis B at a lower dose than for treatment of HIV/AIDS. It improves the seroconversion of e-antigen positive hepatitis B and also improves histology staging of the liver. Long-term use of lamivudine leads to emergence of a resistant hepatitis B virus (YMDD) mutant. [11]
Ad
related to: history of hepatitis b treatment